Insight | Digital players made us relook at almost all our operations in terms of turnaround time, says #Thyrocare CEO Rahul Guha. 

Watch the whole conversation: https://bit.ly/41bzUwo
--------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: http://bit.ly/32JXa74
Visit BQ Prime for more news: https://www.bqprime.com/
Don't enter the stock market unaware. Read all Research Reports here: https://www.bqprime.com/research-reports

For the latest business news and analysis
Subscribe to our Newsletters here: https://www.bqprime.com/my-bq/newsletter
Subscribe to our Telegram channel: https://t.me/BQPrime

Follow BQ Prime here
Twitter: https://twitter.com/bqprime
Facebook: https://www.facebook.com/BQPrime/
LinkedIn: https://www.linkedin.com/company/13184554/
Instagram: https://www.instagram.com/bqprime/
Pinterest: https://in.pinterest.com/BQPrimeNews/

Digital Players Made Us Relook At Almost All Our Operations: Thyrocare CEO Rahul Guha | BQ Prime

Insight | We invested in hiring 40 pathologists in every laboratory to ensure accurate reporting & in a field team that could go out & talk to doctors & pathology labs to grow brand presence, says #Thyrocare CEO Rahul Guha.

Watch the whole conversation: https://bit.ly/41bzUwo
--------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: http://bit.ly/32JXa74
Visit BQ Prime for more news: https://www.bqprime.com/
Don't enter the stock market unaware. Read all Research Reports here: https://www.bqprime.com/research-reports

For the latest business news and analysis
Subscribe to our Newsletters here: https://www.bqprime.com/my-bq/newsletter
Subscribe to our Telegram channel: https://t.me/BQPrime

Follow BQ Prime here
Twitter: https://twitter.com/bqprime
Facebook: https://www.facebook.com/BQPrime/
LinkedIn: https://www.linkedin.com/company/13184554/
Instagram: https://www.instagram.com/bqprime/
Pinterest: https://in.pinterest.com/BQPrimeNews/

Thyrocare CEO Rahul Guha On Margin Expansion Plan | BQ Prime

75% of Thyrocare’s business comes from tier-3 and 4 markets. They witness twice the growth compared to metro cities, says the CEO Rahul Guha. 

Watch the whole conversation: https://bit.ly/41bzUwo

--------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: http://bit.ly/32JXa74
Visit BQ Prime for more news: https://www.bqprime.com/
Don't enter the stock market unaware. Read all Research Reports here: https://www.bqprime.com/research-reports

For the latest business news and analysis
Subscribe to our Newsletters here: https://www.bqprime.com/my-bq/newsletter
Subscribe to our Telegram channel: https://t.me/BQPrime

Follow BQ Prime here
Twitter: https://twitter.com/bqprime
Facebook: https://www.facebook.com/BQPrime/
LinkedIn: https://www.linkedin.com/company/13184554/
Instagram: https://www.instagram.com/bqprime/
Pinterest: https://in.pinterest.com/BQPrimeNews/

Insight | Tier III And IV Key Markets For Thyrocare, Says CEO Rahul Guha | BQ Prime

Thyrocare Technologies shares would turn ex-dividend today. The company had announced an interim dividend of Rs 18 per share. Ex-date for the same is today. The company would pay the dividend on May 7.

Mastek, Tata Communications, Alok Ind Q4 results today; Thyrocare Technologies shares to turn ex-dividend

Know Your Company | KYC में आज Thyrocare के CEO, Rahul Guha से जानेंगे कि Corona की बढ़ती Tension से Testing में हुई बढ़त? CNBC आवाज की खास सीरीज में आज Sumit Mehrotra  बात करेंगे Thyrocare के ... Rahul Guha से |

#thyrocare  #rahulguha #covid  #cnbcawaaz #stockmarketnow  #sharemarket  #cnbcawaazlive #aajkatajakhabar #businessnewslive 

n18oc_business

CNBC Awaaz is one of India’s top business channels and a leader in business news and information for the last ten years. Our channel aims to educate, inform and inspire consumers to go beyond limitations, with practical tips on personal finance, investing, technology, consumer goods and capital markets. Policymakers and business owners alike have grown to trust CNBC Awaaz as the most reliable source with its eye on India’s business climate. Our programming gives consumers a platform to make decisions with confidence.

Subscribe to the CNBC Awaaz YouTube channel here: https://tinyurl.com/y5rsvesk

Follow CNBC Awaaz on Twitter: https://twitter.com/CNBC_Awaaz
Like us on our CNBC Awaaz Facebook page: https://www.facebook.com/cnbcawaaz
Website: https://bit.ly/3230WJW

KYC में आज Thyrocare के CEO, Rahul Guha से जानेंगे कि Corona की बढ़ती Tension से Testing में हुई बढ़त?

Thyrocare has announced the dividend after the launch of its new brand JAANCH.

Thyrocare declares 180% interim dividend on its shares

PharmEasys parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to the goings-on at the company said on condition of anonymity.

Exclusive | Not selling Thyrocare, will cut cash burn: PharmEasy founders to board

The calendar year 2022 saw online platforms like Flipkart, Amazon overtake offline retailers in shipments of smartphones from manufacturing factories, guided by sales and promotions, preferential pricing, and online-exclusive deals and discounts. But this trend might change this year, according to e…

In 2022, etailers trumped offline stores in smartphone shipments; PharmEasy rules out Thyrocare sale

Thyrocare Tech has declared its quarter 3 results. There is Sequential Drop In Revenue and margin hit by lower contribution from Covid-19 biz. If you look at year on year basis, our non covid business recovered very strongly. We grew 20% YoY basis in non covid business and 9% in Covid-19 related businesses.
#thyrocaretech #thyrocaretechperformance #thyrocaretechrevenue
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► https://goo.gl/SEjvK3

Subscribe Now To Our Network Channels :-
Times Now  : http://goo.gl/U9ibPb
The NewsHour Debate : http://goo.gl/LfNgFF

To Stay Updated Download the Times Now App :-
Android Google Play :  https://goo.gl/zJhWjC
Apple App Store :  https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

Thyrocare Tech Q3 | Expansion Plans For 2023 | Sequential Drop In Revenue | Rahul Guha | ET Now

“I have been guiding in all our investor calls that margin will be in that 30% ballpark. As I said in the last quarter, given that we have a lot of dollar exposure on our raw materials, we saw some price hikes from our vendors but we were able to pass them through into the market to maintain the pri…

Thyrocare CEO speaks on margin contraction; says not in talks to sell stake at present

Thyrocare Technologies consolidated net profit declines 31.63% in the December 2022 quarter

Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Thyrocare Technologies Limited is a diagnostic chain company which offers a range of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.